Enables several functions, including ion binding activity; molecular condensate scaffold activity; and potassium channel inhibitor activity. Involved in several processes, including cell volume homeostasis; cellular hyperosmotic response; and negative regulation of protein localization to plasma membrane. Located in cytosol and membrane. Is active in GABA-ergic synapse and intracellular non-membrane-bounded organelle. Biomarker of transient cerebral ischemia. Human ortholog(s) of this gene implicated in hereditary sensory and autonomic neuropathy type 2A; hereditary sensory neuropathy; hypertension; and pseudohypoaldosteronism. Orthologous to human WNK1 (WNK lysine deficient protein kinase 1); PARTICIPATES IN Erk5 MAPK signaling pathway; INTERACTS WITH 17alpha-ethynylestradiol; 2,3,7,8-tetrachlorodibenzodioxine; 2,3,7,8-Tetrachlorodibenzofuran.
hereditary sensory neuropathy, type II; Hsn2; Prkwnk1; protein kinase lysine-deficient 1; protein kinase with no lysine 1; protein kinase, lysine deficient 1; protein kinase, lysine-deficient 1; serine/threonine-protein kinase WNK1
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of WNK1 mRNA
[bisphenol F co-treated with Fulvestrant] results in increased methylation of WNK1 gene and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of WNK1 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of WNK1 mRNA
[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of WNK1 gene more ...
[bisphenol A co-treated with Fulvestrant] results in increased methylation of WNK1 gene and [bisphenol F co-treated with Fulvestrant] results in increased methylation of WNK1 gene
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of WNK1 mRNA
[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WNK1 mRNA
[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of WNK1 mRNA